Aligma

Aligma is a groundbreaking biotechnology company with a mission to transform microalgae into a range of bulk raw materials for various industries. The company's focus lies in producing products for food supplements, food additives, pet food, animal feed, beauty and wellness products, bio-stimulants, and bio-polymers. Their commitment to organic cultivation processes and reducing carbon emissions through photosynthesis underscores their dedication to sustainability. By leveraging micro-algae, Aligma aims to address critical global challenges such as reducing plastic waste, minimizing pressure on agricultural land, and contributing to food security. Since its establishment in 2022, Aligma has positioned itself within the Biopharma and Biotechnology sectors, with its headquarters based in Singapore. However, it is noteworthy that there is no publicly available information regarding the company's latest investment round or the involved investors. This could indicate that Aligma may either be self-funded or in the early stages of seeking external investment to bolster its operations and scale its innovative solutions. As the sustainability and biotechnology sectors continue to garner significant interest from investors, Aligma presents an intriguing opportunity for venture capital firms looking to support environmentally conscious and forward-thinking initiatives at the intersection of technology and sustainability.